News

EIT Health and IHI join forces to drive breakthroughs in health research and innovation

Published on | 2 years ago

Programmes Health EIT

EIT Health and the Innovative Health Initiative Joint Undertaking have signed a Memorandum of Understanding (MoU) that will facilitate collaboration and allow them to leverage their strengths, networks and expertise.

Both organisations receive EU funding under Horizon Europe, and the Memordandum of Understanding is in line with a wider drive to encourage EU programmes to build synergies with one another where relevant. Concretely, the MoU between EIT Health and IHI focuses on the identification of areas of mutual interest and means of collaboration.

More details in the respective press releases on the EIT Health website and on the IHI website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1601 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.